SARAH RUTH GOODYEAR
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology SELLERSVILLE, PA NPI 1891728622
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology PA Alexion Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$4,528.75
- Category: General Payments
- Program years: PY2018–2024
- Record count: 213
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,118.93 across 45 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,118.93 | 45 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | $113.73 | 1 |
| ABBVIE INC. | $99.74 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $97.48 | 4 |
| Acerta Pharma LLC | $77.34 | 4 |
| Janssen Biotech, Inc. | $55.67 | 3 |
| Genentech USA, Inc. | $52.52 | 3 |
| Daiichi Sankyo Inc. | $43.12 | 2 |
| Blueprint Medicines Corporation | $38.66 | 1 |
| EMD Serono, Inc. | $38.00 | 1 |
| Pharmacosmos Therapeutics Inc. | $36.98 | 2 |
| AVEO Pharmaceuticals, Inc. | $36.31 | 2 |
| GlaxoSmithKline, LLC. | $29.39 | 1 |
| GENZYME CORPORATION | $29.08 | 1 |
| Lilly USA, LLC | $26.95 | 1 |
| ARRAY BIOPHARMA INC | $26.90 | 1 |
| BeiGene USA, Inc. | $26.48 | 1 |
| Ipsen Biopharmaceuticals, Inc | $26.27 | 1 |
| Exelixis Inc. | $25.97 | 1 |
| Merck Sharp & Dohme Corporation | $25.68 | 1 |
| Genmab U.S., Inc. | $24.45 | 1 |
| Incyte Corporation | $23.39 | 1 |
| Myriad Genetic Laboratories, Inc. | $22.58 | 1 |
| SERVIER PHARMACEUTICALS LLC | $22.19 | 1 |
| SpringWorks Therapeutics, Inc. | $21.84 | 1 |
| SOBI, INC | $21.47 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.55 | 1 |
| EISAI INC. | $20.33 | 1 |
| Tempus AI, Inc | $18.72 | 1 |
| JAZZ PHARMACEUTICALS INC. | $17.14 | 1 |
By program year
Records — PY2024 (45)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.